Plus Nanoscope Therapeutics applies for FDA approval and Metrocrest Hospital Authority's nonprofit grants.

About this study The purpose of this study is to evaluate the efficacy and safety of Avacopan together with low-dose glucocorticoid in the treatment of patients with crescentic IgAN and high risk of ...